Sandostatin LAR depot 20 MG KTS
Ended Awarded Last action
- Contract number
- SPE2DR26F9MZ6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,164
Award facts
- Contract value 100% obligated
- $20,164.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $20,164.28, was awarded on January 26, 2026, to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 20 mg kits. The award was made by the Defense Logistics Agency under a firm fixed-price contract type with no set-aside designation. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 27, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order was issued under Cencora, Inc.'s Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This comprehensive vehicle enables the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. Sandostatin LAR Depot is a long-acting octreotide formulation used for treating acromegaly and neuroendocrine tumors, consistent with the contractor's portfolio of specialty medications delivered across multiple therapeutic domains to Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9MZ6?
SPE2DR26F9MZ6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F9MZ6 worth?
The government has obligated $20,164 on SPE2DR26F9MZ6.
Is contract SPE2DR26F9MZ6 an order under another contract?
Yes. SPE2DR26F9MZ6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MZ6 competed?
The extent of competition for SPE2DR26F9MZ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award